Prophylactic Anticoagulation May Cut COVID-19 Mortality
FRIDAY, Feb. 12, 2021 -- Prophylactic anticoagulation is associated with reduced risk of 30-day mortality among patients admitted to hospital with severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection, according to a study published online Feb. 11 in The BMJ.
Christopher T. Rentsch, Ph.D., from the London School of Hygiene & Tropical Medicine, and colleagues conducted an observational study involving 4,297 patients admitted to hospital with laboratory-confirmed SARS-CoV-2 infection with no history of anticoagulation.
Of the patients, 84.4 percent received prophylactic anticoagulation within 24 hours of admission; more than 99 percent of treated patients received subcutaneous heparin or enoxaparin. The researchers identified 622 deaths within 30 days of hospital admission: 513 among those who received prophylactic anticoagulation. Eighty-two percent of the deaths occurred during hospital stay. The cumulative incidence of 30-day mortality was 14.3 and 18.7 percent, respectively, among those who received and did not receive prophylactic anticoagulation. The risk of 30-day mortality was significantly reduced for patients who did versus those who did not receive prophylactic anticoagulation (hazard ratio, 0.73; 95 percent confidence interval, 0.66 to 0.81). Similar associations were observed for inpatient mortality and initiation of therapeutic anticoagulation. No significant association was seen for receipt of prophylactic anticoagulation with increased risk of bleeding that required transfusion (hazard ratio, 0.87; 95 percent confidence interval, 0.71 to 1.05).
"Our results provide strong real world evidence to support guidelines recommending the use of prophylactic anticoagulation as initial treatment for patients with COVID-19 on hospital admission," the authors write
Several authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 1 to 5, 2021. This roundup...
FRIDAY, March 5, 2021 -- Countries worldwide are struggling to find enough syringes to administer COVID-19 vaccines. Experts say between 8 billion and 10 billion syringes are...
FRIDAY, March 5, 2021 -- Two cases of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 identified in Minnesota are described in a report published in...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.